These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32235878)

  • 1. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.
    Gopalakrishnan R; Matta H; Choi S; Chaudhary PM
    Sci Rep; 2020 Mar; 10(1):5712. PubMed ID: 32235878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.
    Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R
    J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
    Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
    Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
    Ueno M; Kariya R; Sittithumcharee G; Okada S
    Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A purine scaffold HSP90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.
    Gopalakrishnan R; Matta H; Chaudhary PM
    Clin Cancer Res; 2013 Sep; 19(18):5016-26. PubMed ID: 23881928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.
    Van Goietsenoven G; Mathieu V; Lefranc F; Kornienko A; Evidente A; Kiss R
    Med Res Rev; 2013 Mar; 33(2):439-55. PubMed ID: 22419031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
    Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.
    Van Goietsenoven G; Hutton J; Becker JP; Lallemand B; Robert F; Lefranc F; Pirker C; Vandenbussche G; Van Antwerpen P; Evidente A; Berger W; Prévost M; Pelletier J; Kiss R; Kinzy TG; Kornienko A; Mathieu V
    FASEB J; 2010 Nov; 24(11):4575-84. PubMed ID: 20643906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts.
    Dumont P; Ingrassia L; Rouzeau S; Ribaucour F; Thomas S; Roland I; Darro F; Lefranc F; Kiss R
    Neoplasia; 2007 Sep; 9(9):766-76. PubMed ID: 17898872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway.
    Goto H; Kariya R; Shimamoto M; Kudo E; Taura M; Katano H; Okada S
    Cancer Sci; 2012 Apr; 103(4):775-81. PubMed ID: 22320346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological evaluation of ent-narciclasine, ent-lycoricidine, and certain enantiomerically-related congeners.
    Matveenko M; Banwell MG; Joffe M; Wan S; Fantino E
    Chem Biodivers; 2009 May; 6(5):685-91. PubMed ID: 19479847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties.
    Fürst R
    Planta Med; 2016 Nov; 82(16):1389-1394. PubMed ID: 27542176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
    Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
    Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
    Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design.
    Evidente A; Kireev AS; Jenkins AR; Romero AE; Steelant WF; Van Slambrouck S; Kornienko A
    Planta Med; 2009 Apr; 75(5):501-7. PubMed ID: 19235683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narciclasine-4-
    Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
    Nat Prod Res; 2020 Jan; 34(2):233-240. PubMed ID: 30636443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
    Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
    Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.